The US Food and Drug Administration on Tuesday issued a positively-worded briefing document about the Moderna Covid-19 vaccine ahead of a meeting by professionals on regardless of whether to grant it emergency approval.
The FDA was upbeat on the vaccine, saying there had been “no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization) and confirmed an overall efficacy of 94.1 per cent.”
()